Hyperferritinaemia: An Iron Sword of Autoimmunity.

Joanna Giemza-Stokłosa, Md Asiful Islam, Przemysław J Kotyla

Journal: Current pharmaceutical design 2020;25(27):2909-2918

PMID: 31686632

Abstract

[{"label":"BACKGROUND","text":"Ferritin is a molecule that plays many roles being the storage for iron, signalling molecule, and modulator of the immune response."},{"label":"METHODS","text":"Different electronic databases were searched in a non-systematic way to find out the literature of interest."},{"label":"RESULTS","text":"The level of ferritin rises in many inflammatory conditions including autoimmune disorders. However, in four inflammatory diseases (i.e., adult-onset Still's diseases, macrophage activation syndrome, catastrophic antiphospholipid syndrome, and sepsis), high levels of ferritin are observed suggesting it as a remarkable biomarker and pathological involvement in these diseases. Acting as an acute phase reactant, ferritin is also involved in the cytokine-associated modulator of the immune response as well as a regulator of cytokine synthesis and release which are responsible for the inflammatory storm."},{"label":"CONCLUSION","text":"This review article presents updated information on the role of ferritin in inflammatory and autoimmune diseases with an emphasis on hyperferritinaemic syndrome."},{"copyright":"Copyright\u00a9 Bentham Science Publishers; For any queries, please email at [email protected]."}]
Address: Department of Neurology, Regional Hospital in Oswiecim, 32-600 Oswiecim, Poland.; Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.; Department of Internal Medicine, Rheumatology and Clinical Immunology, Faculty in Katowice, Medical University of Silesia, 40-635 Katowice, Poland.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.